Daniel M. Ramos, DDS, PhD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Daniel M. Ramos, DDS, PhD

Associate Professor, Department of Orofacial Sciences, UCSF

daniel.ramos@ucsf.edu

Phone: (415) 502-4905 (voice)
Box 0512, UCSF
San Francisco, CA 94143-0512

View on UCSF Profiles

Cancer Center Membership

Associate Member » Non-aligned

Education

California State University, Los Angeles, B.S., 1984, Biology
University of California, San Francisco, D.D.S., 1988, Dentistry
University of California, San Francisco, Ph.D., 1994, Oral Biology


Professional Experience

  • 1983-84
    Lab Assistant, Independent Research Project: Tyrosinase Levels in Avian Tissues, California State University, Los Angeles, Department of Biology, Advisor: Dr. Roger Bowers
  • 1985-94
    Postgraduate Research Dentist, University of California, San Francisco, Dept. of Stomatology, Advisor: Dr. Randall Kramer
  • 1994-97
    Adjunct Assistant Professor, University of California, San Francisco, Dept. of Stomatology
  • 1997-2003
    Assistant Professor, University of California, San Francisco, Dept. of Stomatology
  • 2003-present
    Associate Professor, University of California, San Francisco, Department of Stomatology

Honors & Awards

  • 1988-93
    Individual Dentist Scientist Award, NIH-NIDR 1K15DE00242
  • 1995-96
    Junior Faculty Development Award (Academic Senate)
  • 2001
    Dean's Creativity Award (School of Dentistry)

Selected Publications

  1. Lee C, Lee C, Atakilit A, Siu A, Ramos DM. Differential spheroid formation by oral cancer cells. Anticancer Res. 2014 Dec; 34(12):6945-9.
    View on PubMed
  2. Lee C, Lee C, Lee S, Siu A, Ramos DM. The cytoplasmic extension of the integrin ß6 subunit regulates epithelial-to-mesenchymal transition. Anticancer Res. 2014 Feb; 34(2):659-64.
    View on PubMed
  3. Siu A, Chang J, Lee C, Lee S, Lee C, Ramos DM. Expression of EMMPRIN modulates mediators of tumor invasion in oral squamous cell carcinoma. J Calif Dent Assoc. 2013 Nov; 41(11):831-8.
    View on PubMed
  4. Lee C, Siu A, Chang J, Dang D, Ramos DM. Alphavbeta3 suppresses the RhoA-LIMK1 pathway in K1735 melanoma. J Calif Dent Assoc. 2012 Dec; 40(12):921-7.
    View on PubMed
  5. Siu A, Lee C, Pham E, Ramos DM. Revisiting epithelial-to-mesenchymal transition through adenoid cystic carcinoma. Anticancer Res. 2012 Sep; 32(9):3683-8.
    View on PubMed
  6. Siu A, Lee C, Dang D, Lee C, Ramos DM. Stem cell markers as predictors of oral cancer invasion. Anticancer Res. 2012 Apr; 32(4):1163-6.
    View on PubMed
  7. Ramos DM, Dang D. EMMPRIN expression in oral SCC is regulated by FYN kinase. Anticancer Res. 2011 Apr; 31(4):1205-9.
    View on PubMed
  8. Lewin B, Siu A, Baker C, Dang D, Schnitt R, Eisapooran P, Ramos DM. Expression of Fyn kinase modulates EMT in oral cancer cells. Anticancer Res. 2010 Jul; 30(7):2591-6.
    View on PubMed
  9. Dang D, Sadler S, Ramos DM. Modulation of EGFR by oral squamous cell carcinoma cell lines. J Calif Dent Assoc. 2009 Dec; 37(12):869-74.
    View on PubMed
  10. Dang D, Ramos DM. Identification of {alpha}v{beta}6-positive stem cells in oral squamous cell carcinoma. Anticancer Res. 2009 Jun; 29(6):2043-9.
    View on PubMed
  11. Ramos DM, Dang D, Sadler S. The role of the integrin alpha v beta6 in regulating the epithelial to mesenchymal transition in oral cancer. Anticancer Res. 2009 Jan; 29(1):125-30.
    View on PubMed
  12. Dang D, Atakilit A, Ramos DM. EMMPRIN modulates migration and deposition of TN-C in oral squamous carcinoma. Anticancer Res. 2008 Jul-Aug; 28(4B):2049-54.
    View on PubMed
  13. Dang D, Bamburg JR, Ramos DM. Alphavbeta3 integrin and cofilin modulate K1735 melanoma cell invasion. Exp Cell Res. 2006 Feb 15; 312(4):468-77.
    View on PubMed
  14. Mogi S, Dang D, Van Waes C, Ellis D, Atakilit A, Ramos DM. The expression of integrin alpha(v)beta6 promotes the epithelial cell morphology and suppresses invasive behavior in transformed oral keratinocytes. Anticancer Res. 2005 Mar-Apr; 25(2A):751-5.
    View on PubMed
  15. Westernoff TH, Jordan RC, Regezi JA, Ramos DM, Schmidt BL. Beta-6 Integrin, tenascin-C, and MMP-1 expression in salivary gland neoplasms. Oral Oncol. 2005 Feb; 41(2):170-4.
    View on PubMed
  16. Yang Y, Dang D, Mogi S, Ramos DM. Tenascin-C deposition requires beta3 integrin and Src. Biochem Biophys Res Commun. 2004 Sep 24; 322(3):935-42.
    View on PubMed
  17. Dang D, Yang Y, Li X, Atakilit A, Regezi J, Eisele D, Ellis D, Ramos DM. Matrix metalloproteinases and TGFbeta1 modulate oral tumor cell matrix. Biochem Biophys Res Commun. 2004 Apr 9; 316(3):937-42.
    View on PubMed
  18. Yang Y, Dang D, Atakilit A, Schmidt B, Regezi J, Li X, Eisele D, Ellis D, Ramos DM. Specific alpha v integrin receptors modulate K1735 murine melanoma cell behavior. Biochem Biophys Res Commun. 2003 Sep 5; 308(4):814-9.
    View on PubMed
  19. Li X, Yang Y, Hu Y, Dang D, Regezi J, Schmidt BL, Atakilit A, Chen B, Ellis D, Ramos DM. Alphavbeta6-Fyn signaling promotes oral cancer progression. J Biol Chem. 2003 Oct 24; 278(43):41646-53.
    View on PubMed
  20. Regezi JA, Dekker NP, Ramos DM, Li X, Macabeo-Ong M, Jordan RC. Proliferation and invasion factors in HIV-associated dysplastic and nondysplastic oral warts and in oral squamous cell carcinoma: an immunohistochemical and RT-PCR evaluation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 Dec; 94(6):724-31.
    View on PubMed

Go to UCSF Profiles, powered by CTSI